Richard T Marconi Selected Research

OspC protein

1/2019	Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
12/2016	Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
4/2010	Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.
12/2005	Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard T Marconi Research Topics

Disease

27	Infections 01/2021 - 08/2002
22	Lyme Disease (Disease, Lyme) 01/2021 - 06/2003
9	Relapsing Fever 11/2016 - 08/2003
6	Periodontal Diseases (Periodontal Disease) 01/2021 - 11/2005
4	Anaplasmosis 12/2020 - 08/2014
1	Coinfection 12/2020
1	Scrub Typhus (Typhus, Scrub) 06/2018
1	Abscess 07/2016
1	Periodontitis 04/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2002
11	Complement Factor H (Factor H)IBA 04/2012 - 06/2003
10	VaccinesIBA 01/2021 - 12/2005
9	1-oleoyl-2-stearoylphosphatidylcholineIBA 01/2020 - 12/2005
8	EpitopesIBA 07/2019 - 08/2002
6	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 12/2004
5	Carrier Proteins (Binding Protein)IBA 04/2012 - 06/2003
4	OspC proteinIBA 01/2019 - 12/2005
4	LigandsIBA 02/2015 - 11/2007
4	Complement System Proteins (Complement)IBA 04/2012 - 08/2003
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 12/2005
3	bis(3',5')-cyclic diguanylic acidIBA 01/2018 - 07/2011
2	AntibodiesIBA 12/2020 - 10/2009
2	DisulfidesIBA 01/2020 - 01/2020
2	Protein Disulfide-IsomerasesIBA 01/2020 - 01/2020
2	Biological ProductsIBA 07/2019 - 08/2003
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 06/2011
2	diguanylate cyclaseIBA 11/2016 - 07/2011
2	Blood Proteins (Serum Proteins)IBA 05/2008 - 03/2006
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021
1	Karyopherins (Importin)IBA 01/2021
1	LipidsIBA 10/2020
1	OMPA outer membrane proteinsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	EnzymesIBA 01/2020
1	tris(2-carboxyethyl)phosphineIBA 01/2020
1	amixicileIBA 12/2018
1	Polysaccharides (Glycans)IBA 01/2017
1	OspA proteinIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	AntigensIBA 01/2017
1	Subunit VaccinesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 12/2016
1	Histidine KinaseIBA 11/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2016
1	dentilisinIBA 07/2016
1	Peptide Hydrolases (Proteases)FDA Link 07/2016
1	F-Box ProteinsIBA 10/2015
1	Protein SIBA 10/2015
1	cefovecinIBA 07/2015
1	Doxycycline (Periostat)FDA LinkGeneric 07/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2015
1	Amoxicillin (Wymox)FDA LinkGeneric 07/2015
1	P-SelectinIBA 02/2015
1	Glycoproteins (Glycoprotein)IBA 02/2015
1	FucoseIBA 02/2015
1	Sialyl Lewis X AntigenIBA 02/2015
1	SugarsIBA 02/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 02/2015
1	Immune Sera (Antisera)IBA 08/2014
1	Salivary Proteins and PeptidesIBA 08/2011
1	Green Fluorescent ProteinsIBA 07/2011
1	PlasminogenIBA 05/2008
1	A-factor (Streptomyces)IBA 08/2006
1	Methylnitronitrosoguanidine (MNNG)IBA 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2005

Therapy/Procedure

1	Oral Administration 07/2015